Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Allogene Overland Biopharm

Headquarters: N/A
Website: N/A
Year Founded: 2020
Status: Private
BioCentury | Jun 21, 2021
Management Tracks

WuXi vet Yao joins Allogene Overland as CEO; plus uniQure, Merck, Exelixis and Pharming

Allogene Overland Biopharm, a joint venture between Overland Pharmaceuticals and Allogene Therapeutics Inc. (NASDAQ:ALLO) focused on bringing allogeneic cell therapies to China, named
BioCentury | Apr 2, 2021
Product Development

Chinese biotechs look to next-generation CAR T technologies to solve market challenges

Chinese CAR T cell companies are mapping out solutions to their cost problem
BioCentury | Feb 5, 2021
Emerging Company Profile

Deals with Allogene, ADC reflect Overland’s ambition to tap parent Hillhouse’s network to bring innovation to China

Emerging Company Profile: Overland aims to bring innovative Western therapies to China
Items per page:
1 - 3 of 3